Table 4 Adverse obstetric and neonatal outcomes stratified by timing of diagnosis and the three most frequent cancer site. Lombardy, Italy. 2008–2017
During Pregnancy Cancers | Post-pregnancy Cancer | |||||
|---|---|---|---|---|---|---|
Breast N=69 | Thyroid N=17 | Lymphoma N=18 | Breast N=190 | Thyroid N=121 | Lymphoma N=85 | |
Obstetric outcomes | ||||||
Labor induction or planning of delivery b | ||||||
Not Induced | 12 (17.9) | 8 (47.1) | 3 (17.6) | 109 (58.0) | 66 (55.0) | 52 (61.2) |
Induced or Elective CS | 55 (82.1) | 9 (52.9) | 14 (82.4) | 79 (42.0) | 54 (45.0) | 33 (38.8) |
p value a = 0.048 | p value = 0.675 | |||||
Mode of Delivery c | ||||||
Vaginal or Instrumental | 31 (44.9) | 12 (70.6) | 6 (35.3) | 129 (57.9) | 88 (72.7) | 58 (69.1) |
CS | 38 (55.1) | 5 (29.4) | 11 (64.7) | 61 (32.1) | 33 (27.3) | 26 (30.9) |
p value = 0.089 | p value = 0.659 | |||||
Timing of Birth | ||||||
At Term | 33 (47.8) | 14 (82.4) | 10 (55.6) | 170 (89.5) | 111 (91.7) | 79 (92.9) |
Preterm | 36 (52.2) | 3 (17.6) | 8 (44.4) | 20 (10.5) | 10 (8.3) | 6 (7.1) |
p value = 0.037 | p value = 0.607 | |||||
Neonatal outcomes | ||||||
SGA | ||||||
No | 69 (100.0) | 16 (94.1) | 16 (88.9) | 172 (90.5) | 116 (95.9) | 74 (87.1) |
Yes | 0 (0.0) | 1 (5.9) | 2 (11.1) | 18 (9.5) | 5 (4.1) | 11 (12.9) |
p value a = 0.036 | p value = 0.071 | |||||
Apgar 5th Minute | ||||||
Normal | 66 (95.6) | 17 (100.0) | 18 (100.0) | 188 (99.0) | 120 (99.2) | 85 (100.0) |
Low | 3 (4.4) | 0 (0.0) | 0 (0.0) | 2 (1.0) | 1 (0.8) | 0 (0.0) |
p value a = 1.000 | p value a = 1.000 | |||||
Malformation | ||||||
No | 69 (100.0) | 17 (100.0) | 18 (100.0) | 190 (100.0) | 119 (98.4) | 85 (100.0) |
Yes | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (1.6) | 0 (0.0) |
– | p value a = 0.139 | |||||
Perinatal Mortality | ||||||
Livebirth | 69 (100.0) | 17 (100.0) | 18 (100.0) | 190 (100.0) | 120 (99.2) | 85 (100.0) |
Stillbirth | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (0.8) | 0 (0.0) |
– | p value a = 0.520 | |||||